Friday 6 November 2026 Export RLAY’s income statement to Excel — free account

Relay Therapeutics, Inc.

Relay Therapeutics, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $15.4 million, up 53.4% from fiscal 2024.

Revenue: −95.4%
EPS: 0.00%
Free cash flow: +2.13%

Quarter to June 2026, against a year earlier

18.44 1.44 +8.47%

Follow RLAY

Alert me

Market cap: $3.7B
P/E: 0.0×
Fwd P/E: −11.4×
Dividend yield: —
F-score: 5/9
Altman Z: 10.99
Beneish M: n/a
Dividend safety: n/a

Overview

Relay Therapeutics, Inc. (RLAY) P/B ratio

Alert me on P/B ratio

As of 5 November 2026, Relay Therapeutics, Inc. (RLAY) trades at a P/B ratio of 3.9×. Over the past ten years it has ranged from 0.0× (September 2020) to 6.0× (November 2021); the current reading is higher than 77% of that period. That is above the Biotechnology industry median of 2.0× and above the Healthcare sector median of 2.3×.

Embed this chart

Code for your page

<iframe src="https://stockrow.com/embed/RLAY/pb-ratio" width="100%" height="360" style="border:0" loading="lazy" title="Relay Therapeutics, Inc. P/B ratio, 10 years"></iframe>
<p style="font-size:12px">Source: <a href="https://stockrow.com/RLAY/metrics/pb-ratio">Relay Therapeutics, Inc. (RLAY) P/B ratio — stockrow.com</a></p>

Period	P/B ratio	Change
FY2025	2.6×	238.25%
FY2024	0.8×	(60.85%)
FY2023	1.9×	8.83%
FY2022	1.8×	(45.41%)
FY2021	3.3×	40.23%
FY2020	2.3×	—

Period	P/B ratio	Change
Jun 2026	4.3×	53.03%
Mar 2026	2.8×	8.86%
Dec 2025	2.6×	187.56%
Jun 2025	0.9×	44.77%
15 more quarters	Free account

Against its own ten years

Low 0.0× High 6.0×

Ten-year median 2.1×

Current reading's percentile 76

Company	P/B ratio
PBLS Parabilis Medicines, Inc. compare	0.8×
ACAD ACADIA Pharmaceuticals Inc. compare	2.6×
XENE Xenon Pharmaceuticals Inc. compare	3.0×
TNGX Tango Therapeutics, Inc. compare	3.1×
ABCL AbCellera Biologics Inc. compare	3.8×
RLAY Relay Therapeutics, Inc.	3.9×
IOVA Iovance Biotherapeutics, Inc. compare	4.3×
IRON Disc Medicine, Inc. compare	4.7×
EWTX Edgewise Therapeutics, Inc. compare	9.4×
Biotechnology industry median	2.0×
Healthcare sector median	2.3×
Market median	1.7×

What P/B ratio is

Price to Book Value tells an investor how much the market pays for a company’s shares relative to the accounting net worth that belongs to common shareholders.

Stock Price ÷ (Common Equity (Total) (latest quarter) ÷ Shares (Basic, Weighted) (latest quarter))

The full definition of P/B ratio →

Relay Therapeutics, Inc. (RLAY) P/B ratio

P/B ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/B ratio against peers

What P/B ratio is

More on RLAY

P/B ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/B ratio against peers

What P/B ratio is

More on RLAY

Stockrow Weekly